Comparative-effectiveness research of COVID-19 treatment: a rapid scoping review.

ABSTRACT:

Objectives

The COVID-19 pandemic has stimulated growing research on treatment options. We aim to provide an overview of the characteristics of studies evaluating COVID-19 treatment.

Design

Rapid scoping review DATA SOURCES: Medline, Embase and biorxiv/medrxiv from inception to 15 May 2021.

Setting

Hospital and community care.

Participants

COVID-19 patients of all ages.

Interventions

COVID-19 treatment.

Results

The literature search identified 616 relevant primary studies of which 188 were randomised controlled trials and 299 relevant evidence syntheses. The studies and evidence syntheses were conducted in 51 and 39 countries, respectively.Most studies enrolled patients admitted to acute care hospitals (84%), included on average 169 participants, w

SUBMITTER: Pham B 

PROVIDER: S-EPMC9170799 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature